xDRIVE for Florida-based Cancer Patients
Part of paid clinical trials in Miami, Florida.
- Sponsor
- First Ascent Biomedical Inc.
- Study ID
- NCT07167381
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- xDRIVE Tumor Profiling — DIAGNOSTIC_TESTPatients and physicians will receive tumor profiling data via xDRIVE Functional Precision Medicine and Artificial Intelligence analysis. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment.
Study Details
Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment. The investigator will run a prospective single-arm feasibility study providing the xDRIVE FPM AI platform to n = 210+ cancer patients throughout the state of Florida, especially those from underserved populations (pediatric patients and patients in Black, Brown, Hispanic, and rural communities).
Key Dates
- Start date
- Nov 1, 2025
- Status verified
- May 2026
- Primary completion
- Nov 1, 2026
- Completion
- Apr 1, 2027
Study Design
- Enrollment
- 210 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: xDRIVE ProfilingPatients will receive tumor profiling via xDRIVE Functional Precision Medicine and Artificial Intelligence analysis
Primary Outcome Measure
Return of treatment recommendations from xDRIVE functional precision medicine platform within a clinically-actionable timeframe [ Time Frame: Return of xDRIVE data will be completed in under 2 weeks ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| First Ascent Biomedical | Miami | Florida | 33183 | |
| Florida International University | Miami | Florida | 33199 | - |
Find similar trials in Miami, FL
Related Studies
- Caris Biorepository Research ProtocolRecruiting · Caris Science, Inc. · Mobile, Alabama
- Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-upRecruiting · Center for Biomedical Research, LLC · Jacksonville, Florida
- Immune Reconstitution in Stem Cell Transplant RecipientsRecruiting · University of Miami · Miami, Florida
- Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Miami, Florida